66 related articles for article (PubMed ID: 3442958)
1. Follow-up renal biopsies in IgA nephritic patients on triple therapy.
Woo KT; Chiang GS; Lim CH
Clin Nephrol; 1987 Dec; 28(6):304-5. PubMed ID: 3442958
[No Abstract] [Full Text] [Related]
2. Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide.
Brodsky SV; Rovin BH; Hebert LA
Nephrol Dial Transplant; 2012 Feb; 27(2):475-7. PubMed ID: 21948859
[No Abstract] [Full Text] [Related]
3. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin.
Woo KT; Lee GS
Clin Nephrol; 1991 Apr; 35(4):184. PubMed ID: 1855324
[No Abstract] [Full Text] [Related]
4. Effects of triple therapy in IgA nephritis: a follow-up study 5 years later.
Woo KT; Lee GS; Lau YK; Chiang GS; Lim CH
Clin Nephrol; 1991 Aug; 36(2):60-6. PubMed ID: 1934661
[TBL] [Abstract][Full Text] [Related]
5. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
Walker RG; Yu SH; Owen JE; Kincaid-Smith P
Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
[TBL] [Abstract][Full Text] [Related]
6. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
[TBL] [Abstract][Full Text] [Related]
7. A case of IgA nephritis showing diffuse podocytic detachment from the glomerular basement membrane.
Moriya T; Nakazawa K; Itoh N; Shigematsu H; Higuchi M; Miyasaka M; Oguchi H
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):423-30. PubMed ID: 1635288
[TBL] [Abstract][Full Text] [Related]
8. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
McIntyre CW; Fluck RJ; Lambie SH
Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial of dipyridamole and low-dose warfarin in patients with IgA nephritis with renal impairment.
Lee GS; Woo KT; Lim CH
Clin Nephrol; 1989 May; 31(5):276. PubMed ID: 2661066
[No Abstract] [Full Text] [Related]
10. ANCA-associated crescentic IgA glomerulonephritis in pregnancy.
Amir AR; Sheikh SS
J Nephrol; 2002; 15(6):716-9. PubMed ID: 12495291
[TBL] [Abstract][Full Text] [Related]
11. Treatment of vasculitic IgA nephropathy.
Harper L; Ferreira MA; Howie AJ; Savage CO; Richards NT; Michael J; Adu D
J Nephrol; 2000; 13(5):360-6. PubMed ID: 11063140
[TBL] [Abstract][Full Text] [Related]
12. Dipyridamole and low-dose warfarin without cyclophosphamide in the management of IgA nephropathy.
Woo KT; Lee GS; Pall AA
Kidney Int; 2000 Jan; 57(1):348-9. PubMed ID: 10712116
[No Abstract] [Full Text] [Related]
13. Behcet's disease and IgA nephropathy: report of this association in a patient from Brazil and literature review.
Fernandes PF; Júnior GB; Barros FA; Sousa DC; Franco LM; Patrocínio RM
Invest Clin; 2006 Dec; 47(4):405-11. PubMed ID: 17176908
[TBL] [Abstract][Full Text] [Related]
14. IgA nephritis in Singapore: clinical, prognostic indices, and treatment.
Woo KT; Chiang GS; Lau YK; Lim CH
Semin Nephrol; 1987 Dec; 7(4):379-81. PubMed ID: 3445021
[No Abstract] [Full Text] [Related]
15. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
[TBL] [Abstract][Full Text] [Related]
16. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
Yoshikawa N; Honda M; Iijima K; Awazu M; Hattori S; Nakanishi K; Ito H;
Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
[TBL] [Abstract][Full Text] [Related]
17. [The course and prognosis of mesangioproliferative glomerulonephritis].
Shilov EM; Tareeva IE; Ivanov AA; Troepol'skaia OV; Krasnova TN; Varshavskiĭ VA; Proskurneva EP; Ivanova LV; Khudova IIu; Miroshnichenko NG
Ter Arkh; 2002; 74(6):11-8. PubMed ID: 12136475
[TBL] [Abstract][Full Text] [Related]
18. Controlled therapeutic trial of IgA nephritis with follow-up renal biopsies.
Woo KT; Chiang GS; Yap HK; Lim CH
Ann Acad Med Singap; 1988 Apr; 17(2):226-31. PubMed ID: 3408224
[TBL] [Abstract][Full Text] [Related]
19. IgA nephropathy in renal transplant recipients: is it a significant cause of allograft failure?
Park SB; Joo I; Suk J; Cho WH; Park CH; Kim SP; Park KK; Kim HC
Transplant Proc; 1996 Jun; 28(3):1540-2. PubMed ID: 8658777
[No Abstract] [Full Text] [Related]
20. Vasculitic IgA nephropathy: prognosis and outcome.
Pankhurst T; Lepenies J; Nightingale P; Howie AJ; Adu D; Harper L
Nephron Clin Pract; 2009; 112(1):c16-24. PubMed ID: 19342865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
